{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T11:14:12Z","timestamp":1721733252726},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Eine telemedizinische Versorgung kann neue Einsatzm\u00f6glichkeiten bereits etablierter Therapeutika wie einer tragbaren Defibrillator-Weste (WCD) erm\u00f6glichen und \u00fcber ein verbessertes Management von hier\u00fcber abgeleiteten Vitaldaten die Versorgungsqualit\u00e4t von chronisch kranken Patienten mit Herzinsuffizienz (HI) erh\u00f6hen. Im aktuellen Fallbericht wird der klinische Verlauf eines 71\u00a0Jahre alten Patienten beschrieben, der nach einer akuten kardialen Dekompensation und neudiagnostizierter hochgradiger Einschr\u00e4nkung der kardialen Pumpfunktion im Rahmen einer isch\u00e4mischen Kardiomyopathie leitliniengerecht mit einer WCD bis zur endg\u00fcltigen Entscheidung \u00fcber eine ICD-Implantation versorgt wurde. Die durch die WCD gesammelten Vitalwerte wurden \u00fcber ein Telemedizinzentrum (TMZ) strukturiert ausgewertet und hierbei ein Rezidiv des vorbekannten paroxysmalen Vorhofflimmerns (VHF) entdeckt, was vor einer m\u00f6glichen Dekompensation durch Anpassung der Medikation und fr\u00fchzeitiger Initiierung einer Pulmonalvenenisolation (PVI) therapiert werden konnte. Dieser Fall zeigt exemplarisch die Sinnhaftigkeit strukturierter telemedizinischer Intervention auf, die es erm\u00f6glicht, etablierte Konzepte der Patientenversorgung sinnvoll zu erg\u00e4nzen, bestehende Konzepte zu optimieren und die Patientenversorgung signifikant zu verbessern.<\/jats:p>","DOI":"10.1007\/s00399-021-00769-0","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T16:03:19Z","timestamp":1620835399000},"page":"264-268","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Der Wearable Kardioverter-Defibrillator als Diagnostikum"],"prefix":"10.1007","volume":"32","author":[{"given":"Tobyson","family":"Pulickal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Helms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A.","family":"Perings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"769_CR1","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori\u00a0SG, Blomstr\u00f6m-Lundqvist\u00a0C, Mazzanti\u00a0A et al (2015) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart\u00a0J 36:2793\u20132867. https:\/\/doi.org\/10.1093\/eurheartj\/ehv316","journal-title":"Eur Heart J"},{"key":"769_CR2","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.115.015677","volume":"132","author":"V Kutyifa","year":"2015","unstructured":"Kutyifa\u00a0V, Moss\u00a0AJ, Klein\u00a0H et al (2015) Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the prospective registry of patients using the Wearable Cardioverter Defibrillator (WEARIT-II registry). Circulation 132:1613\u20131619. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015677","journal-title":"Circulation"},{"key":"769_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/europace\/euw180","volume":"19","author":"S Reek","year":"2017","unstructured":"Reek\u00a0S, Burri\u00a0H, Roberts\u00a0PR et al (2017) The wearable cardioverter-defibrillator: current technology and evolving indications. Europace 19:335\u2013345. https:\/\/doi.org\/10.1093\/europace\/euw180","journal-title":"Europace"},{"key":"769_CR4","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1056\/NEJMoa1800781","volume":"379","author":"JE Olgin","year":"2018","unstructured":"Olgin\u00a0JE, Pletcher\u00a0MJ, Vittinghoff\u00a0E et al (2018) Wearable cardioverter-defibrillator after myocardial infarction. N\u00a0Engl J Med 379:1205\u20131215. https:\/\/doi.org\/10.1056\/NEJMoa1800781","journal-title":"N Engl J Med"},{"key":"769_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jacep.2018.11.011","volume":"5","author":"A Masri","year":"2019","unstructured":"Masri\u00a0A, Altibi\u00a0AM, Erqou\u00a0S et al (2019) Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a systematic review and meta-analysis. JACC Clin Electrophysiol 5:152\u2013161. https:\/\/doi.org\/10.1016\/j.jacep.2018.11.011","journal-title":"JACC Clin Electrophysiol"},{"key":"769_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10741-019-09801-5","volume":"25","author":"Y Zhu","year":"2020","unstructured":"Zhu\u00a0Y, Gu\u00a0X, Xu\u00a0C (2020) Effectiveness of telemedicine systems for adults with heart failure: a\u00a0meta-analysis of randomized controlled trials. Heart Fail Rev 25:231\u2013243. https:\/\/doi.org\/10.1007\/s10741-019-09801-5","journal-title":"Heart Fail Rev"},{"key":"769_CR7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(18)31880-4","volume":"392","author":"F Koehler","year":"2018","unstructured":"Koehler\u00a0F, Koehler\u00a0K, Deckwart\u00a0O et al (2018) Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a\u00a0randomised, controlled, parallel-group, unmasked trial. Lancet 392:1047\u20131057. https:\/\/doi.org\/10.1016\/S0140-6736(18)31880-4","journal-title":"Lancet"},{"key":"769_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski\u00a0P, Voors\u00a0AA, Anker\u00a0SD et\u00a0al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart\u00a0J 37:2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"769_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002606","author":"TM Ruppar","year":"2016","unstructured":"Ruppar\u00a0TM, Cooper\u00a0PS, Mehr\u00a0DR et al (2016) Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials. J\u00a0Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.115.002606","journal-title":"J Am Heart Assoc"},{"key":"769_CR10","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/eurheartj\/ehi166","volume":"26","author":"K Swedberg","year":"2005","unstructured":"Swedberg\u00a0K, Olsson\u00a0LG, Charlesworth\u00a0A et al (2005) Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart\u00a0J 26:1303\u20131308. https:\/\/doi.org\/10.1093\/eurheartj\/ehi166","journal-title":"Eur Heart J"},{"key":"769_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche\u00a0NF, Brachmann\u00a0J, Andresen\u00a0D et\u00a0al (2018) Catheter ablation for atrial fibrillation with heart failure. N\u00a0Engl J Med 378:417\u2013427. https:\/\/doi.org\/10.1056\/NEJMoa1707855","journal-title":"N Engl J Med"},{"key":"769_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ehjcvp\/pvy011","volume":"5","author":"NE Ibrahim","year":"2019","unstructured":"Ibrahim\u00a0NE, Gaggin\u00a0HK, Turchin\u00a0A et al (2019) Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction. Eur Heart J Cardiovasc Pharmacother 5:3\u201311. https:\/\/doi.org\/10.1093\/ehjcvp\/pvy011","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"769_CR13","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.amjcard.2018.12.032","volume":"123","author":"CG Jungbauer","year":"2019","unstructured":"Jungbauer\u00a0CG, Maier\u00a0LS, Emoto\u00a0K et al (2019) Achieving guideline-directed heart rate ControlEarly posthospitalization. Am J Cardiol 123:1096\u20131100. https:\/\/doi.org\/10.1016\/j.amjcard.2018.12.032","journal-title":"Am J Cardiol"},{"key":"769_CR14","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1016\/j.ijcard.2013.07.171","volume":"168","author":"M Jehn","year":"2013","unstructured":"Jehn\u00a0M, Prescher\u00a0S, Koehler\u00a0K et al (2013) Tele-accelerometry as a\u00a0novel technique for assessing functional status in patients with heart failure: feasibility, reliability and patient safety. Int J Cardiol 168:4723\u20134728. https:\/\/doi.org\/10.1016\/j.ijcard.2013.07.171","journal-title":"Int J Cardiol"},{"key":"769_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/2047487316671438","volume":"23","author":"S Prescher","year":"2016","unstructured":"Prescher\u00a0S, Schoebel\u00a0C, Koehler\u00a0K et al (2016) Prognostic value of serial six-minute walk tests using tele-accelerometry in patients with chronic heart failure: a pre-specified sub-study of the TIM-HF-Trial. Eur J Prev Cardiolog 23:21\u201326. https:\/\/doi.org\/10.1177\/2047487316671438","journal-title":"Eur J Prev Cardiolog"},{"key":"769_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(14)61176-4","volume":"384","author":"G Hindricks","year":"2014","unstructured":"Hindricks\u00a0G, Taborsky\u00a0M, Glikson\u00a0M et al (2014) Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a\u00a0randomised controlled trial. Lancet 384:583\u2013590. https:\/\/doi.org\/10.1016\/S0140-6736(14)61176-4","journal-title":"Lancet"},{"key":"769_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/jce.14404","volume":"31","author":"JE Olgin","year":"2020","unstructured":"Olgin\u00a0JE, Lee\u00a0BK, Vittinghoff\u00a0E et al (2020) Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: as-treated and per-protocol analyses. J\u00a0Cardiovasc Electrophysiol 31:1009\u20131018. https:\/\/doi.org\/10.1111\/jce.14404","journal-title":"J Cardiovasc Electrophysiol"},{"key":"769_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00399-018-0606-7","volume":"30","author":"TM Helms","year":"2019","unstructured":"Helms\u00a0TM, Stockburger\u00a0M, K\u00f6hler\u00a0F et al (2019) Grundlegende Strukturmerkmale eines kardiologischen Telemedizinzentrums f\u00fcr Patienten mit Herzinsuffizienz und implantierten Devices, Herzrhythmusst\u00f6rungen und erh\u00f6htem Risiko f\u00fcr den pl\u00f6tzlichen Herztod: Empfehlungen der Arbeitsgruppe 33 Telemonitoring in der Deutschen Gesellschaft f\u00fcr Kardiologie, Herz- und Kreislaufforschung e.V. Herzschrittmacherther Elektrophysiol 30:136\u2013142. https:\/\/doi.org\/10.1007\/s00399-018-0606-7","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"769_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00399-019-0630-2","volume":"30","author":"TM Helms","year":"2019","unstructured":"Helms\u00a0TM, Stockburger\u00a0M, K\u00f6hler\u00a0F et\u00a0al (2019) Positionspapier Telemonitoring: Von den Nukleusmitgliedern der AG33 Telemonitoring in der DGK und assoziierten Mitgliedern. Herzschrittmacherther Elektrophysiol 30:287\u2013297. https:\/\/doi.org\/10.1007\/s00399-019-0630-2","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"769_CR20","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/S2589-7500(19)30195-5","volume":"2","author":"F Koehler","year":"2020","unstructured":"Koehler\u00a0F, Koehler\u00a0K, Prescher\u00a0S et al (2020) Mortality and morbidity 1\u00a0year after stopping a\u00a0remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial. Lancet Digit Health 2:e16\u2013e24. https:\/\/doi.org\/10.1016\/S2589-7500(19)30195-5","journal-title":"Lancet Digit Health"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-021-00769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-021-00769-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-021-00769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T12:10:11Z","timestamp":1622463011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-021-00769-0"}},"subtitle":["Fallbeispiel aus dem telemedizinischen Alltag"],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["769"],"URL":"https:\/\/doi.org\/10.1007\/s00399-021-00769-0","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"11 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Pulickal, T.\u00a0M.\u00a0Helms und C.\u00a0A.\u00a0Perings geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}